Cited by

• Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.

  Narayan RR, Creasy JM, Goldman DA, Gönen M, Kandoth C, Kundra R, Solit DB, Askan G, Klimstra DS, Basturk O, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Drebin JA, Kingham TP, Simpson AL, Abou-Alfa GK, Harding JJ, O'Reilly EM, Butte JM, Matsuyama R, Endo I, Jarnagin WR. Narayan RR, et al. Cancer. 2019 Feb 15;125(4):575-585. doi: 10.1002/cncr.31850. Epub 2018 Nov 14. Cancer. 2019. PMID: 30427539 Free PMC article.
• TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway.

  Zhang Y, Du P, Li Y, Zhu Q, Song X, Liu S, Hao J, Liu L, Liu F, Hu Y, Jiang L, Ma Q, Lu W, Liu Y. Zhang Y, et al. Int J Biol Sci. 2020 Jan 14;16(5):739-751. doi: 10.7150/ijbs.40516. eCollection 2020. Int J Biol Sci. 2020. PMID: 32071545 Free PMC article.
• Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.

  De Minicis S, Kisseleva T, Francis H, Baroni GS, Benedetti A, Brenner D, Alvaro D, Alpini G, Marzioni M. De Minicis S, et al. Dig Liver Dis. 2013 Jun;45(6):450-9. doi: 10.1016/j.dld.2012.10.008. Epub 2012 Nov 22. Dig Liver Dis. 2013. PMID: 23177172 Free PMC article. Review.
• Study of self-expandable metallic stent placement intraluminal ¹²⁵I seed strands brachytherapy of malignant biliary obstruction.

  Jiao D, Wu G, Ren J, Han X. Jiao D, et al. Surg Endosc. 2017 Dec;31(12):4996-5005. doi: 10.1007/s00464-017-5481-5. Epub 2017 Jun 22. Surg Endosc. 2017. PMID: 28643064 Clinical Trial.
• MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.

  Li M, Chen W, Zhang H, Zhang Y, Ke F, Wu X, Zhang Y, Weng M, Liu Y, Gong W. Li M, et al. Oncotarget. 2016 Dec 13;7(50):83060-83070. doi: 10.18632/oncotarget.13067. Oncotarget. 2016. PMID: 27825112 Free PMC article.